Array Biopharma Inc
ARRY
ARRY was delisted on the 29th of July, 2019.
133 hedge funds and large institutions have $1.05B invested in Array Biopharma Inc in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 15 closing their positions.
80% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 15
79% more capital invested
Capital invested by funds: $587M → $1.05B (+$464M)
57% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 35
32% more call options, than puts
Call options by funds: $25.1M | Put options by funds: $19M
9% more funds holding
Funds holding: 122 → 133 (+11)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.1M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$30.1M |
| 3 |
O
OrbiMed
New York
|
+$14.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$12.9M |
| 5 |
Millennium Management
New York
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$16.8M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.27M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.72M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.27M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.93M |
ARRY Hedge Fund Activity: Q1 2015 in Review
133 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2015, worth a combined $1.05B — up 79% from $587M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ARRY positions and 15 closed out — a net gain of 12 holders — while 55 added to existing stakes and 35 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $52.1M. The largest seller was BVF Inc, cutting an estimated $16.8M.
- 133 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2015, up from 122 in Q4 2014.
- Funds reported $1.05B of Array Biopharma Inc stock for Q1 2015, up 79% quarter-over-quarter.
- 27 funds opened new Array Biopharma Inc positions in Q1 2015 and 15 closed out, a net change of +12 holders.
- The largest Array Biopharma Inc buyer in Q1 2015 was Fidelity Investments, an estimated $52.1M added.
- The largest Array Biopharma Inc seller in Q1 2015 was BVF Inc, an estimated $16.8M sold.
Based on aggregated 13F filings for Q1 2015.